| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.4 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |